3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
2
Plasma cell
1
Other neoplasm
1
Other hematologic neoplasm
1
Lymphoid
1
Genitourinary
1
Classical hematology
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Multiple Myeloma
2
Leukemia, Myeloid, Acute
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Interventions
Cyclophosphamide
207
fludarabine phosphate
182
Azacitidine
153
fludarabine
141
Busulfan
139
Tacrolimus
118
Mycophenolic Acid
111
Cytarabine
110
Whole-Body Irradiation
105
Peripheral Blood Stem Cell Transplantation
97
Antilymphocyte Serum
95
Melphalan
89
Filgrastim
86
Cyclosporine
81
Methotrexate
78
Decitabine
78
venetoclax
63
Granulocyte Colony-Stimulating Factor
56
Radiotherapy
49
Stem Cell Transplantation
48
Thiotepa
46
Cord Blood Stem Cell Transplantation
43
thymoglobulin
41
Clofarabine
41
Etoposide
35
Specimen Handling
34
Methylprednisolone
34
Sirolimus
33
Biopsy
27
Injections
26
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Molecular Diagnostic Techniques
×
Other hematologic neoplasm
×
Clear all
NCT02435550
2019-12-20
iCare for Cancer Patients
University of Florida
Phase NA
Terminated
136 enrolled